Skip to main content
. 2009 Nov 5;181(4):315–323. doi: 10.1164/rccm.200906-0896OC

TABLE 3.

BIOMARKERS IN SUBSET OF SUBJECTS*

Cluster 1
Cluster 2
Cluster 3
Cluster 4
Cluster 5
n Value n Value n Value n Value n Value P Value
PC20 methacholine, mg/ml 100 1.17 (0.73) 268 1.12 (0.67) 39 2.32 (0.60) 64 0.73 (0.71) 15 0.72 (0.86) 0.007
FeNO, ppb 90 32.8 (0.36) 257 28.0 (0.37) 47 24.8 (0.36) 93 26.8 (0.37) 84 29.3 (0.41) 0.40
Blood/serum
 Total IgE, IU/ml 91 141 (0.71) 257 125 (0.71) 47 54 (0.82) 90 132 (0.65) 87 98 (0.62) 0.008
 % Eosinophils 96 0.2 (0.42) 272 0.2 (0.5) 51 0.2 (0.42) 106 0.3 (0.46) 97 0.2 (0.6) 0.29
Sputum induction 63 160 30 60 44
 % Eosinophils 0.7 (0.2–4.4) 0.7 (0.1–3.7) 1.9 (0.0–4.5) 1.5 (0.3–7.9) 1.2 (0.0–10.1) 0.05
 % Neutrophils 23.3 (7.4–42.9) 33.0 (15.7–51.7) 37.6 (12.7–66.4) 34.7 (15.2–65.7) 48.3 (25.7–80.3) 0.001

Definition of abbreviation: FeNO = fractional concentration of nitric oxide in exhaled air; PC20 = concentration of methacholine that causes a 20% fall in FEV1.

*

Subjects with FEV1 less than 55% predicted pretesting were excluded from methacholine challenge and sputum induction.

Data expressed as geometric mean (log 10 SD).

Data expressed as median (interquartile range).